Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1685 entries
Sorted by: Best Match Show Resources per page
Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study.

Journal of clinical and diagnostic research : JCDR

Hussain SS, Farhat S, Rather YH, Abbas Z.
PMID: 25738001
J Clin Diagn Res. 2015 Jan;9(1):FC01-4. doi: 10.7860/JCDR/2015/10625.5425. Epub 2015 Jan 01.

OBJECTIVES: Prevalence of opioid addiction has alarmingly increased over the recent years. In South Asian region alone there are more than 10 million opioid abusers amounting to 2% of world population. Detoxification remains to be the first step for...

Cite
Hussain SS, Farhat S, Rather YH, et al. Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. J Clin Diagn Res. 2015;9(1):FC01-4doi: 10.7860/JCDR/2015/10625.5425.
Hussain, S. S., Farhat, S., Rather, Y. H., & Abbas, Z. (2015). Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. Journal of clinical and diagnostic research : JCDR, 9(1), FC01-4. https://doi.org/10.7860/JCDR/2015/10625.5425
Hussain, Syed Sajad, et al. "Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study." Journal of clinical and diagnostic research : JCDR vol. 9,1 (2015): FC01-4. doi: https://doi.org/10.7860/JCDR/2015/10625.5425
Hussain SS, Farhat S, Rather YH, Abbas Z. Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. J Clin Diagn Res. 2015 Jan;9(1):FC01-4. doi: 10.7860/JCDR/2015/10625.5425. Epub 2015 Jan 01. PMID: 25738001; PMCID: PMC4347092.
Copy Download .nbib Format: NLM
In response to: Do heroin overdose patients require observation after receiving naloxone?.

Clinical toxicology (Philadelphia, Pa.)

Eggleston W, Clemency BM.
PMID: 28140683
Clin Toxicol (Phila). 2017 Apr;55(4):308. doi: 10.1080/15563650.2017.1284336. Epub 2017 Jan 31.

No abstract available.

Cite
Eggleston W, Clemency BM. In response to: Do heroin overdose patients require observation after receiving naloxone?. Clin Toxicol (Phila). 2017;55(4):308doi: 10.1080/15563650.2017.1284336.
Eggleston, W., & Clemency, B. M. (2017). In response to: Do heroin overdose patients require observation after receiving naloxone?. Clinical toxicology (Philadelphia, Pa.), 55(4), 308. https://doi.org/10.1080/15563650.2017.1284336
Eggleston, William, and Clemency, Brian M. "In response to: Do heroin overdose patients require observation after receiving naloxone?." Clinical toxicology (Philadelphia, Pa.) vol. 55,4 (2017): 308. doi: https://doi.org/10.1080/15563650.2017.1284336
Eggleston W, Clemency BM. In response to: Do heroin overdose patients require observation after receiving naloxone?. Clin Toxicol (Phila). 2017 Apr;55(4):308. doi: 10.1080/15563650.2017.1284336. Epub 2017 Jan 31. PMID: 28140683.
Copy Download .nbib Format: NLM
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Therapeutic advances in gastroenterology

Zelber-Sagi S, Godos J, Salomone F.
PMID: 27134667
Therap Adv Gastroenterol. 2016 May;9(3):392-407. doi: 10.1177/1756283X16638830. Epub 2016 Mar 17.

Nonalcoholic fatty liver disease (NAFLD) is emerging as a major public health problem because of its association with increased cardiovascular and liver-related morbidity and mortality. Both genetic factors and lifestyle contribute to the pathogenesis of NAFLD. Lifestyle, including dietary...

Cite
Zelber-Sagi S, Godos J, Salomone F. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol. 2016;9(3):392-407doi: 10.1177/1756283X16638830.
Zelber-Sagi, S., Godos, J., & Salomone, F. (2016). Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therapeutic advances in gastroenterology, 9(3), 392-407. https://doi.org/10.1177/1756283X16638830
Zelber-Sagi, Shira, et al. "Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials." Therapeutic advances in gastroenterology vol. 9,3 (2016): 392-407. doi: https://doi.org/10.1177/1756283X16638830
Zelber-Sagi S, Godos J, Salomone F. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol. 2016 May;9(3):392-407. doi: 10.1177/1756283X16638830. Epub 2016 Mar 17. PMID: 27134667; PMCID: PMC4830109.
Copy Download .nbib Format: NLM
Availability of naloxone in Canadian pharmacies:a population-based survey.

CMAJ open

Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN.
PMID: 29117991
CMAJ Open. 2017 Nov 08;5(4):E779-E784. doi: 10.9778/cmajo.20170123.

BACKGROUND: Naloxone is life-saving when administered after opioid overdose. In March 2016, the Canadian government made the antidote available without prescription, but anecdotal reports suggest members of the public have difficulty in procuring it. We examined the availability of...

Cite
Cressman AM, Mazereeuw G, Guan Q, et al. Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ Open. 2017;5(4):E779-E784doi: 10.9778/cmajo.20170123.
Cressman, A. M., Mazereeuw, G., Guan, Q., Jia, W., Gomes, T., & Juurlink, D. N. (2017). Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ open, 5(4), E779-E784. https://doi.org/10.9778/cmajo.20170123
Cressman, Alex M, et al. "Availability of naloxone in Canadian pharmacies:a population-based survey." CMAJ open vol. 5,4 (2017): E779-E784. doi: https://doi.org/10.9778/cmajo.20170123
Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN. Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ Open. 2017 Nov 08;5(4):E779-E784. doi: 10.9778/cmajo.20170123. PMID: 29117991; PMCID: PMC5741422.
Copy Download .nbib Format: NLM
Antinociceptive effect of aqueous extracts from the bark of Croton guatemalensis Lotsy in mice.

Research in pharmaceutical sciences

Del Carmen RO, Willam HM, Del Carmen GM, Nataly JG, Stefany CO, Anahi CA, Domingo PT, Leonardo GP, Miguel Pde L.
PMID: 27051428
Res Pharm Sci. 2016 Jan-Feb;11(1):15-22.

Croton guatemalensis Lotsy (CGL), known as "copalchi" in Chiapas, Mexico, is used for the treatment of fever, abdominal pain and malaria and also as a remedy for chills and for treating rheumatism. The aim of this study was to...

Cite
Del Carmen RO, Willam HM, Del Carmen GM, et al. Antinociceptive effect of aqueous extracts from the bark of Croton guatemalensis Lotsy in mice. Res Pharm Sci. 2016;11(1):15-22
Del Carmen, R. O., Willam, H. M., Del Carmen, G. M., Nataly, J. G., Stefany, C. O., Anahi, C. A., Domingo, P. T., Leonardo, G. P., & Miguel, P. d. e. . L. (2016). Antinociceptive effect of aqueous extracts from the bark of Croton guatemalensis Lotsy in mice. Research in pharmaceutical sciences, 11(1), 15-22.
Del Carmen, Rejón-Orantes José, et al. "Antinociceptive effect of aqueous extracts from the bark of Croton guatemalensis Lotsy in mice." Research in pharmaceutical sciences vol. 11,1 (2016): 15-22.
Del Carmen RO, Willam HM, Del Carmen GM, Nataly JG, Stefany CO, Anahi CA, Domingo PT, Leonardo GP, Miguel Pde L. Antinociceptive effect of aqueous extracts from the bark of Croton guatemalensis Lotsy in mice. Res Pharm Sci. 2016 Jan-Feb;11(1):15-22. PMID: 27051428; PMCID: PMC4794933.
Copy Download .nbib Format: NLM
Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention.

World journal of gastrointestinal surgery

Catena F, Di Saverio S, Coccolini F, Ansaloni L, De Simone B, Sartelli M, Van Goor H.
PMID: 27022449
World J Gastrointest Surg. 2016 Mar 27;8(3):222-31. doi: 10.4240/wjgs.v8.i3.222.

Intra-abdominal adhesions following abdominal surgery represent a major unsolved problem. They are the first cause of small bowel obstruction. Diagnosis is based on clinical evaluation, water-soluble contrast follow-through and computed tomography scan. For patients presenting no signs of strangulation,...

Cite
Catena F, Di Saverio S, Coccolini F, et al. Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention. World J Gastrointest Surg. 2016;8(3):222-31doi: 10.4240/wjgs.v8.i3.222.
Catena, F., Di Saverio, S., Coccolini, F., Ansaloni, L., De Simone, B., Sartelli, M., & Van Goor, H. (2016). Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention. World journal of gastrointestinal surgery, 8(3), 222-31. https://doi.org/10.4240/wjgs.v8.i3.222
Catena, Fausto, et al. "Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention." World journal of gastrointestinal surgery vol. 8,3 (2016): 222-31. doi: https://doi.org/10.4240/wjgs.v8.i3.222
Catena F, Di Saverio S, Coccolini F, Ansaloni L, De Simone B, Sartelli M, Van Goor H. Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention. World J Gastrointest Surg. 2016 Mar 27;8(3):222-31. doi: 10.4240/wjgs.v8.i3.222. PMID: 27022449; PMCID: PMC4807323.
Copy Download .nbib Format: NLM
Prolonged receptor blockade by opioid receptor probes.

Pharmaceutical research

Koman A, Kolb VM, Terenius L.
PMID: 24271359
Pharm Res. 1986 Feb;3(1):56-60. doi: 10.1023/A:1016329000518.

Opioid receptor interactions of morphinan-type opioids derivatized at the C-6 carbon were investigated. The compounds, designed as probes for studying opioid receptors, were characterized with regard to affinity for the rat brain mu receptor by competition with tritium-labeled dihydromorphine...

Cite
Koman A, Kolb VM, Terenius L. Prolonged receptor blockade by opioid receptor probes. Pharm Res. 1986;3(1):56-60doi: 10.1023/A:1016329000518.
Koman, A., Kolb, V. M., & Terenius, L. (1986). Prolonged receptor blockade by opioid receptor probes. Pharmaceutical research, 3(1), 56-60. https://doi.org/10.1023/A:1016329000518
Koman, A, et al. "Prolonged receptor blockade by opioid receptor probes." Pharmaceutical research vol. 3,1 (1986): 56-60. doi: https://doi.org/10.1023/A:1016329000518
Koman A, Kolb VM, Terenius L. Prolonged receptor blockade by opioid receptor probes. Pharm Res. 1986 Feb;3(1):56-60. doi: 10.1023/A:1016329000518. PMID: 24271359.
Copy Download .nbib Format: NLM
Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain.

Basic and clinical neuroscience

Kesmati M, Torabi M.
PMID: 25436088
Basic Clin Neurosci. 2014;5(1):80-7.

INTRODUCTION: Today Nano-medicine tries to produce new drugs to reduce the dosage and side effects of their conventional forms. According to the interaction between zinc and opioidergic system activity, this study has investigated the effect of new kind of...

Cite
Kesmati M, Torabi M. Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain. Basic Clin Neurosci. 2014;5(1):80-7
Kesmati, M., & Torabi, M. (2014). Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain. Basic and clinical neuroscience, 5(1), 80-7.
Kesmati, Mahnaz, and Torabi, Mozhgan. "Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain." Basic and clinical neuroscience vol. 5,1 (2014): 80-7.
Kesmati M, Torabi M. Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain. Basic Clin Neurosci. 2014;5(1):80-7. PMID: 25436088; PMCID: PMC4202607.
Copy Download .nbib Format: NLM
HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily.

Oncology letters

Ieni A, Barresi V, Giuffrè G, Caruso RA, Lanzafame S, Villari L, Salomone E, Roz E, Cabibi D, Franco V, Certo G, Labate A, Nagar C, Magliolo E, Broggi B, Fazzari C, Italia F, Tuccari G.
PMID: 24260051
Oncol Lett. 2013 Dec;6(6):1591-1594. doi: 10.3892/ol.2013.1611. Epub 2013 Oct 10.

According to the ToGA trial, HER2 has been shown to be predictive for the success of treatment with trastuzumab in advanced gastric cancer (AGC). A number of studies have analyzed HER-2/neu overexpression in gastric carcinoma and identified the rate...

Cite
Ieni A, Barresi V, Giuffrè G, et al. HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. Oncol Lett. 2013;6(6):1591-1594doi: 10.3892/ol.2013.1611.
Ieni, A., Barresi, V., Giuffrè, G., Caruso, R. A., Lanzafame, S., Villari, L., Salomone, E., Roz, E., Cabibi, D., Franco, V., Certo, G., Labate, A., Nagar, C., Magliolo, E., Broggi, B., Fazzari, C., Italia, F., & Tuccari, G. (2013). HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. Oncology letters, 6(6), 1591-1594. https://doi.org/10.3892/ol.2013.1611
Ieni, A, et al. "HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily." Oncology letters vol. 6,6 (2013): 1591-1594. doi: https://doi.org/10.3892/ol.2013.1611
Ieni A, Barresi V, Giuffrè G, Caruso RA, Lanzafame S, Villari L, Salomone E, Roz E, Cabibi D, Franco V, Certo G, Labate A, Nagar C, Magliolo E, Broggi B, Fazzari C, Italia F, Tuccari G. HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. Oncol Lett. 2013 Dec;6(6):1591-1594. doi: 10.3892/ol.2013.1611. Epub 2013 Oct 10. PMID: 24260051; PMCID: PMC3833944.
Copy Download .nbib Format: NLM
Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens.

Pathogens (Basel, Switzerland)

Brosnahan AJ, Jones BJ, Dvorak CM, Brown DR.
PMID: 25437799
Pathogens. 2014 Apr 02;3(2):249-57. doi: 10.3390/pathogens3020249.

Epithelial cells represent the first line of host immune defense at mucosal surfaces. Although opioids appear to increase host susceptibility to infection, no studies have examined opioid effects on epithelial immune functions. We tested the hypothesis that morphine alters...

Cite
Brosnahan AJ, Jones BJ, Dvorak CM, et al. Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens. Pathogens. 2014;3(2):249-57doi: 10.3390/pathogens3020249.
Brosnahan, A. J., Jones, B. J., Dvorak, C. M., & Brown, D. R. (2014). Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens. Pathogens (Basel, Switzerland), 3(2), 249-57. https://doi.org/10.3390/pathogens3020249
Brosnahan, Amanda J, et al. "Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens." Pathogens (Basel, Switzerland) vol. 3,2 (2014): 249-57. doi: https://doi.org/10.3390/pathogens3020249
Brosnahan AJ, Jones BJ, Dvorak CM, Brown DR. Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens. Pathogens. 2014 Apr 02;3(2):249-57. doi: 10.3390/pathogens3020249. PMID: 25437799; PMCID: PMC4243445.
Copy Download .nbib Format: NLM
Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases.

Indian journal of psychological medicine

Ranjan R, Pattanayak RD, Dhawan A.
PMID: 25336782
Indian J Psychol Med. 2014 Oct;36(4):439-43. doi: 10.4103/0253-7176.140754.

Adolescents constitute only a small percentage of treatment seekers in drug dependence treatment settings. Little research evidence is available for pharmacological treatment of adolescent opioid dependence and no prior case report is available from India. We discuss two adolescent...

Cite
Ranjan R, Pattanayak RD, Dhawan A. Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases. Indian J Psychol Med. 2014;36(4):439-43doi: 10.4103/0253-7176.140754.
Ranjan, R., Pattanayak, R. D., & Dhawan, A. (2014). Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases. Indian journal of psychological medicine, 36(4), 439-43. https://doi.org/10.4103/0253-7176.140754
Ranjan, Rajeev, et al. "Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases." Indian journal of psychological medicine vol. 36,4 (2014): 439-43. doi: https://doi.org/10.4103/0253-7176.140754
Ranjan R, Pattanayak RD, Dhawan A. Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases. Indian J Psychol Med. 2014 Oct;36(4):439-43. doi: 10.4103/0253-7176.140754. PMID: 25336782; PMCID: PMC4201802.
Copy Download .nbib Format: NLM
Potential spawn induction and suppression agents in Caribbean Acropora cervicornis corals of the Florida Keys.

PeerJ

Flint M, Than JT.
PMID: 27168990
PeerJ. 2016 Apr 26;4:e1982. doi: 10.7717/peerj.1982. eCollection 2016.

The enhanced ability to direct sexual reproduction may lead to improved restoration outcomes for Acropora cervicornis. Gravid fragments of A. cervicornis were maintained in a laboratory for two sequential trials in the seven days prior to natural spawning in...

Cite
Flint M, Than JT. Potential spawn induction and suppression agents in Caribbean Acropora cervicornis corals of the Florida Keys. PeerJ. 2016;4:e1982doi: 10.7717/peerj.1982.
Flint, M., & Than, J. T. (2016). Potential spawn induction and suppression agents in Caribbean Acropora cervicornis corals of the Florida Keys. PeerJ, 4e1982. https://doi.org/10.7717/peerj.1982
Flint, Mark, and Than, John T. "Potential spawn induction and suppression agents in Caribbean Acropora cervicornis corals of the Florida Keys." PeerJ vol. 4 (2016): e1982. doi: https://doi.org/10.7717/peerj.1982
Flint M, Than JT. Potential spawn induction and suppression agents in Caribbean Acropora cervicornis corals of the Florida Keys. PeerJ. 2016 Apr 26;4:e1982. doi: 10.7717/peerj.1982. eCollection 2016. PMID: 27168990; PMCID: PMC4860313.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1685 entries